Interstitial granulomatous dermatitis occurring in a patient with SAPHO syndrome one month after starting leflunomide, and subsequently disappearing with ustekinumab

Eur J Dermatol. 2016 Dec 1;26(6):614-615. doi: 10.1684/ejd.2016.2854.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acquired Hyperostosis Syndrome / drug therapy*
  • Adult
  • Dermatitis / drug therapy*
  • Dermatitis / etiology
  • Dermatologic Agents / therapeutic use*
  • Drug Eruptions / drug therapy
  • Drug Eruptions / etiology
  • Female
  • Granuloma / chemically induced
  • Granuloma / drug therapy*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Isoxazoles / adverse effects*
  • Leflunomide
  • Ustekinumab / therapeutic use*

Substances

  • Dermatologic Agents
  • Immunosuppressive Agents
  • Isoxazoles
  • Ustekinumab
  • Leflunomide